|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/24 | |
| C07K 16/28 | |||
| C07K 16/46 |
| (11) | Number of the document | 3192809 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17153380.5 |
| Date of filing the European patent application | 2013-04-16 | |
| (97) | Date of publication of the European application | 2017-07-19 |
| (45) | Date of publication and mention of the grant of the patent | 2020-04-15 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201261636302 P | 2012-04-20 | US | |
| 201361768747 P | 2013-02-25 | US |
| (72) |
Barrett, Allan, US
Benschop, Robert Jan, US
Jirong, Lu, US
|
| (73) |
Eli Lilly and Company,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (54) | ANTI-BAFF-ANTI-IL-17 BISPECIFIC ANTIBODIES |
| ANTI-BAFF-ANTI-IL-17 BISPECIFIC ANTIBODIES |